Shifting to biosimilars, generics helped NHS exceed savings targets by more than 70m pounds in a year.

Use of biosimilars and generics had a profound effect on the savings targets of NHS with NHS saving over £300m in 2017-18. The original savings target for NHS trusts was set at £250m.

Leave a Reply

Your email address will not be published.